Table 1 Factors associated with ESBL-E carriage amongst 1072 internal medicine patients, University of Geneva Hospitals, March-June 20101; univariate and multivariate regression analysis
Proportions (n) | Univariate regression | Multivariate regression | ||||
|---|---|---|---|---|---|---|
Variable | ESBL carriage (n = 51) | No ESBL carriage (n = 1021) | OR [95% CI] | P- value | OR [95% CI] | P- value |
Male gender | 54.9 (28) | 56.9 (581) | 0.92 [0.52-1.62] | 0.778 | ||
Transferred from ICU | 0 | 0.6 (6) | 0.27 [0.36-1.97] | 0.195 | ||
Transferred from other ward (other than the ICU) | 2.0 (1) | 2.5 (25) | 0.80 [0.11-6.00] | 0.825 | ||
Patient admitted from home | 96.1 (49) | 90.7 (925) | 2.52 [0.61-10.62] | 0.201 | ||
Age | ||||||
< =59 y | 37.3 (19) | 33.6 (343) | 1.94 [0.55-6.81] | 0.300 | ||
60 -79 y | 41.2 (21) | 39.5 (403) | 1.62 [0.47-5.52] | 0.443 | ||
> = 80 y | 21.5 (11) | 22.1 (226) | 1.40 [0.38-5.2] | 0.614 | ||
Acute renal failure2 | 20.8 (5) | 23.0 (94) | 0.87 [0.32-2.40] | 0.793 | ||
Chronic renal failure2 | 16.7 (4) | 13.6 (55) | 1.28 [0.42-3.87] | 0.667 | ||
End stage renal failure2 | 4.2 (9) | 2.0 (8) | 2.16 [0.26-18.04] | 0.476 | ||
Diabetes without complications 2 | 33.3 (8) | 15.3 (62) | 2.77 [1.14-6.39] | 0.033 | 2.87 [1.09-7.08] | 0.032 |
Diabetes mellitus (with complications)2 | 12.5 (3) | 10.3 (42) | 1.24 [0.35- 4.33] | 0.706 | ||
Peripheral vascular disease2 | 8.3 (16) | 3.9 (16) | 2.21 [0.48-10.25] | 0.309 | ||
Chronic obstructive airway disease2 | 20.8 (5) | 13.8 (56) | 1.64 [0.59-4.58] | 0.341 | ||
Dementia2 | 0 | 1.2 (5) | Omitted | |||
Stroke2 | 0 | 1.0 (4) | Omitted | |||
Cerebral hemorrhage2 | 0 | 0.5 (2) | Omitted | |||
Congestive cardiac failure2 | 29.2 (7) | 23.7 (96) | 1.33 [0.54-3.30] | 0.539 | ||
Ischemic heart disease2 | 12.5 (3) | 11.1 (45) | 1.15 [0.33-4.00] | 0.831 | ||
Hematological malignancy2 | 0 | 5.4 (22) | Omitted | |||
Carotid artery stenosis2 | 0 | 1.0 (4) | Omitted | |||
Parkinson’s disease2 | 0 | 0.3 (1) | Omitted | |||
Connective tissue disease 2 | 8.3 (5) | 1.0 (4) | 9.14 [1.58-52.62] | 0.013 | 7.22 [1.17-44.59] | 0.033 |
Liver failure 2 | 8.3 (6) | 1.5 (6) | 6.06 [1.15-31.77] | 0.033 | 8.39 [1.55-45.45] | 0.014 |
Respiratory failure2 | 0 | 0.7 (3) | Omitted | |||
Solid organ cancer2 | 4.2 (1) | 17.0 (69) | 0.21 [0.28-1.58] | 0.130 | ||
Metastatic cancer2 | 8.3 (2) | 8.4 (34) | 0.99 [0.22-4.41] | 0.994 | ||
Peptic ulcer disease2 | 4.2 (1) | 2.7 (11) | 1.56 [0.19-12.64] | 0.676 | ||
Infection2 | 0 | 0.9 (4) | Omitted | |||